Advertisement
The Medicine Maker / Issues / 2026 / May / This Weeks Biopharma News Amgen Deepens US Manufacturing Push
Biopharma Biopharma Industry News

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

05/12/2026 6 min read News

Share

Advertisement

Recommended

Advertisement

Related Content

Video: Building the Airplane While Flying It – with Jonny Wray
Biopharma Interviews Business & Trends
Video: Building the Airplane While Flying It – with Jonny Wray

October 16, 2026

1 min read

Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology

Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount
Cell & Gene Industry News
Caribou Halts Allogeneic CAR T Programs as Funding Pressures Mount

October 12, 2026

2 min read

“Caribou’s story has taken a heartbreaking turn,” says CEO Rachel Haurwitz, with the CRISPR-focused biotech set to discontinue vispa-cel and CB-011, and reduce its workforce

This Month’s Manufacturing Moves
Facilities & Equipment Business & Trends Industry News
This Month’s Manufacturing Moves

October 12, 2026

5 min read

Bayer plans a $2.2 billion Ohio campus, Genentech breaks ground in Oregon, and new investments support vaccine production, downstream processing, and manufacturing in orbit

Prula-cel Shows Early Promise in Lupus
Drug Delivery Cell & Gene Industry News
Prula-cel Shows Early Promise in Lupus

October 8, 2026

2 min read

Adicet Bio reports 12-month remission and renal response data for its allogeneic gamma delta CAR T therapy

Advertisement